NAV
$36.08
AUM
$876.4M
Expense Ratio
-
Dividend Yield
2.93%
Beta
0.75
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.14% | +2.10% | +1.86% | +19.06% | +18.47% | +11.71% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | HSBA.L | HSBC Holdings PLC | 9.68% |
| 2 | AZN.L | AstraZeneca PLC | 8.36% |
| 3 | SHEL.L | Shell PLC | 7.18% |
| 4 | RR.L | Rolls-Royce Holdings PLC | 4.59% |
| 5 | BATS.L | British American Tobacco PLC | 3.91% |
| 6 | ULVR.L | Unilever PLC | 3.65% |
| 7 | RIO.L | Rio Tinto PLC Ordinary Shares | 3.33% |
| 8 | BP.L | BP PLC | 3.31% |
| 9 | GSK.L | GSK PLC | 3.04% |
| 10 | BARC.L | Barclays PLC | 2.58% |
Under normal market conditions, the fund invests at least 80% of its assets in the component securities of the FTSE UK Capped Index and in depositary receipts representing such securities. The FTSE UK Capped Index is based on the FTSE UK Index and is designed to measure the performance of United Kingdom large- and mid-capitalization stocks. The fund is non-diversified.
Inception Date: 2017-11-02